| Next 10 |
Search for Articles
Organic Investor Awareness
We have taken the numerous features that companies and investors have grown to love over the past two decades and incorporated them all into one amazing platform. This includes news, trade data, articles, social sharing, profiles, message boards, private messaging, and more. Call 650-412-2222 or Contact us for more information.
Search Results for "Recent Articles"
-
Reviewing the trend for the past 20 trading days there is a potential Short Squeeze about to happen because the past five days have shown an increase in cover volume with very little short volume.
-
The global shower glass door market has been thriving mainly due to increasing urbanization that is creating demand for not-so necessary products, such as shower glass doors.
-
The global ophthalmic lasers market is expected to witness considerable growth during the forecast period owing to rising demand of ophthalmic lasers for the treatment of various diseases, such as glaucoma, cataract and diabetic retinopathy.
-
The cancer/tumor profiling market size is growing at a CAGR of 19.0% during forecast period.
-
Increasing adoption of companion animals, growing consumption of meat and milk, and rising incidence of food-borne zoonotic diseases are the key factors driving the market.
-
Synthetic biology market is expected to grow with a CAGR of 35.4% during forecast period.
-
CrossFit recently announced that after growing privacy concerns and the deletion of the diet group on Facebook, 'Banting7DayMealPlan user group', that it was quitting the social media giant, and Instagram, which is also owned by Facebook.
-
Well cementing market is expected to reach $10,065.4 million by 2024, with a CAGR of 4.7% during the forecast period
-
Global Nanotechnology Market Size: Key Trends shaping $163.3 Billion market to 2025
-
Between October 2018 to March 2019, Facebook has said that it has removed over 3 billion fake accounts. Facebook has stated that these fake accounts were ‘never considered active’ so they were not included in the total count.
Trending News
- AB-729 is a subcutaneously-administered RNAi agent targeting HBV replication and HBsAg antigen production - Supports corporate objective to combine AB-729 with AB-506, Arbutus’ proprietary oral capsid inhibitor WARMINSTER, Pa., June 20, 2019 (GLOBE NEWSWIRE) -- Arbutus Biop...